Quarterly Insider Transactions at Alnylam Pharmaceuticals, Inc. (ALNY)
Shares Bought
Shares Sold
ALNY Insider transactions
| Quarter | Buy / Adquisition | Sell / Disposition | Net Activity | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Traded Shares | Avg. Price /p share | Transactions | Insiders | Traded Shares | Avg. Price /p share | Transactions | Insiders | |||
| Q4 2024 | 30.9K | $0.0 $0 | 7 | 6 | 14.8K | $250.84 $3.71 Million | 36 | 5 | 16.1K | |
| Q3 2024 | 71.1K | $98.2 $6.98 Million | 6 | 3 | 79.5K | $267.59 $21.3 Million | 16 | 3 | (8.39K) | |
| Q2 2024 | 101K | $42.92 $4.35 Million | 10 | 7 | 77.5K | $225.6 $17.5 Million | 67 | 7 | 23.8K | |
| Q1 2024 | 116K | $3.95 $459,219 | 15 | 6 | 46.9K | $154.78 $7.25 Million | 46 | 6 | 69.4K | |
| Q4 2023 | 30K | $96.45 $2.89 Million | 1 | 1 | 30K | $195.0 $5.85 Million | 1 | 1 | 0 | |
| Q3 2023 | 55.6K | $0.0 $0 | 9 | 5 | 25.6K | $186.27 $4.78 Million | 34 | 5 | 30K | |
| Q2 2023 | 33.1K | $0.0 $0 | 5 | 5 | 20.3K | $196.1 $3.97 Million | 32 | 6 | 12.9K | |
| Q1 2023 | 46.8K | $25.59 $1.2 Million | 10 | 9 | 62.8K | $223.11 $14 Million | 19 | 4 | (16K) | |
| Q4 2022 | 27.6K | $67.27 $1.86 Million | 5 | 2 | 23.8K | $223.1 $5.32 Million | 2 | 2 | 3.76K | |
| Q3 2022 | 86.2K | $6.26 $539,980 | 15 | 6 | 63K | $210.99 $13.3 Million | 34 | 6 | 23.2K | |
| Q2 2022 | 15K | $11.33 $169,950 | 1 | 1 | 15K | $172.8 $2.59 Million | 10 | 1 | 0 | |
| Q1 2022 | 35K | $5.67 $198,422 | 2 | 2 | 31.5K | $147.33 $4.64 Million | 2 | 2 | 3.51K | |
| Q4 2021 | 64.3K | $44.23 $2.85 Million | 8 | 3 | 48.6K | $186.9 $9.08 Million | 31 | 3 | 15.8K | |
| Q3 2021 | 115K | $72.02 $8.26 Million | 8 | 4 | 115K | $194.52 $22.3 Million | 10 | 4 | 0 | |
| Q2 2021 | 81.2K | $14.04 $1.14 Million | 8 | 5 | 72.5K | $136.34 $9.89 Million | 27 | 5 | 8.68K | |
| Q1 2021 | 90.2K | $33.13 $2.99 Million | 10 | 4 | 73.2K | $155.03 $11.3 Million | 26 | 4 | 17.1K | |
| Q4 2020 | 315K | $6.94 $2.19 Million | 4 | 3 | 315K | $114.3 $36 Million | 10 | 3 | 0 | |
| Q3 2020 | 971 | $42.22 $40,995 | 1 | 1 | 971 | $140.0 $135,940 | 1 | 1 | 0 | |
| Q4 2019 | 38 | $0.0 $0 | 1 | 1 | — | 38 | ||||
| Q2 2017 | 298K | $71.87 $21.4 Million | 1 | 1 | — | 298K | ||||
| Q1 2016 | 205K | $69.75 $14.3 Million | 1 | 1 | — | 205K | ||||
| Q1 2015 | 941K | $3169.0 $2.98 Billion | 3 | 1 | — | 941K | ||||
| Q1 2014 | 344K | $66.88 $23 Million | 1 | 1 | — | 344K | ||||
| Q3 2012 | — | 1.55M | $19.42 $30.1 Million | 1 | 1 | (1.55M) | ||||
| Q2 2010 | 55.2K | $17.99 $993,461 | 1 | 1 | — | 55.2K | ||||
| Q2 2009 | 65.9K | $17.5 $1.15 Million | 1 | 1 | — | 65.9K | ||||
| Q2 2008 | 214K | $25.29 $5.41 Million | 1 | 1 | — | 214K | ||||